Corient Capital Partners’s Zoetis ZTS Stock Holding History
Bought
Maintained
Sold
Other funds holding ZTS
Corient Capital Partners's ZTS Position: Q3 2022 in Review
Corient Capital Partners increased its Zoetis (ZTS) stake by 0.49% in Q3 2022, buying an estimated $18.1K and bringing the position to 22,340 shares worth $3.84M. The position accounts for 0.29% of the portfolio, ranked #81.
Corient Capital Partners first reported a position in ZTS in Q4 2018 and has held it in 16 quarters since. The position peaked at $4.63M in Q4 2021. 1,508 funds tracked by Wall St. Rank hold ZTS as of Q3 2022.
- Corient Capital Partners held 22,340 shares of Zoetis worth $3.84M as of Q3 2022.
- Corient Capital Partners bought 108 Zoetis shares in Q3 2022, an estimated $18.1K.
- Zoetis made up 0.29% of Corient Capital Partners's portfolio in Q3 2022, its #81 holding.
- Corient Capital Partners first reported a position in Zoetis in Q4 2018 and has held it in 16 quarters since.
- Corient Capital Partners's Zoetis position peaked at $4.63M in Q4 2021.
- 1,508 funds tracked by Wall St. Rank held Zoetis as of Q3 2022.
Based on Corient Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.